Cargando…

Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway

BACKGROUND: Ulcerative colitis (UC) is an intestinal disease which was characterized by intestinal inflammation, mucosal injury and fibrosis. In this paper, the effect of Huanglian Jiedu Decoction (HJD), a well-known traditional Chinese medicine with significant anti-inflammatory effect, on dextran...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhuo, Xiong, Wanna, Xiao, Simeng, Lin, Yilong, Yu, Kai, Yue, Guihua, Liu, Qiaoming, Li, Fang, Liang, Jianqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206681/
https://www.ncbi.nlm.nih.gov/pubmed/32411291
http://dx.doi.org/10.1186/s13020-020-00327-9
_version_ 1783530458413268992
author Lu, Zhuo
Xiong, Wanna
Xiao, Simeng
Lin, Yilong
Yu, Kai
Yue, Guihua
Liu, Qiaoming
Li, Fang
Liang, Jianqin
author_facet Lu, Zhuo
Xiong, Wanna
Xiao, Simeng
Lin, Yilong
Yu, Kai
Yue, Guihua
Liu, Qiaoming
Li, Fang
Liang, Jianqin
author_sort Lu, Zhuo
collection PubMed
description BACKGROUND: Ulcerative colitis (UC) is an intestinal disease which was characterized by intestinal inflammation, mucosal injury and fibrosis. In this paper, the effect of Huanglian Jiedu Decoction (HJD), a well-known traditional Chinese medicine with significant anti-inflammatory effect, on dextran sulphate sodium (DSS)-induced UC in mice and inhibition of JAK2/STAT3 pathway were investigated. METHODS: BALB/c mice were randomly divided into 6 groups: HJD group (high, medium and low dose), USAN group, UC group, and control group. UC in mice were induced through free access to 3% DSS solution. After being treated with HJD for 8 days, all animals were sacrifice. Pathological examination of colonic specimen was performed by H&E staining. Cytokines (TNF-α, IL-6, and IL-1β) in colon were assayed by ELISA and immunofluorescence, MPO in colon and ATT in serum were detected by ELISA. Moreover, mice in HJD group and UC group were treated with AG490 to inhibit the expression of JAK2 protein, then the expression of JAK2 and STAT3 protein in colon was determined by western blotting and immunofluorescence staining. Furthermore, KI67 in colon was examined by immunohistochemistry, and apoptosis was detected by TUNEL staining, and collagen deposition was assayed by Masson staining after JAK2/STAT3 pathway in UC mice was inhibited by HJD. RESULTS: After mice being treated with HJD, the symptoms (weight loss and haematochezia) of UC were alleviated, and the contents of inflammatory cytokines (TNF-α, IL-6 and IL-1β) and MPO in colon were significantly decreased. The expression of JAK2 and STAT3 protein was reduced after administration with HJD. After JAK2/STAT3 pathway being inhibited with HJD, the cell apoptosis, collagen deposition and immunoreactivity of macrophage in colon were significantly reduced, but the expression of Ki67 was markedly enhanced in both UC group and HJD group compare with control group. CONCLUSIONS: HJD treatment can alleviate intestinal mucosal damage and has the protective effect on UC by downregulating JAK2 and STAT3 expression to reduce inflammation via JAK2/STAT3 pathway.
format Online
Article
Text
id pubmed-7206681
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72066812020-05-14 Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway Lu, Zhuo Xiong, Wanna Xiao, Simeng Lin, Yilong Yu, Kai Yue, Guihua Liu, Qiaoming Li, Fang Liang, Jianqin Chin Med Research BACKGROUND: Ulcerative colitis (UC) is an intestinal disease which was characterized by intestinal inflammation, mucosal injury and fibrosis. In this paper, the effect of Huanglian Jiedu Decoction (HJD), a well-known traditional Chinese medicine with significant anti-inflammatory effect, on dextran sulphate sodium (DSS)-induced UC in mice and inhibition of JAK2/STAT3 pathway were investigated. METHODS: BALB/c mice were randomly divided into 6 groups: HJD group (high, medium and low dose), USAN group, UC group, and control group. UC in mice were induced through free access to 3% DSS solution. After being treated with HJD for 8 days, all animals were sacrifice. Pathological examination of colonic specimen was performed by H&E staining. Cytokines (TNF-α, IL-6, and IL-1β) in colon were assayed by ELISA and immunofluorescence, MPO in colon and ATT in serum were detected by ELISA. Moreover, mice in HJD group and UC group were treated with AG490 to inhibit the expression of JAK2 protein, then the expression of JAK2 and STAT3 protein in colon was determined by western blotting and immunofluorescence staining. Furthermore, KI67 in colon was examined by immunohistochemistry, and apoptosis was detected by TUNEL staining, and collagen deposition was assayed by Masson staining after JAK2/STAT3 pathway in UC mice was inhibited by HJD. RESULTS: After mice being treated with HJD, the symptoms (weight loss and haematochezia) of UC were alleviated, and the contents of inflammatory cytokines (TNF-α, IL-6 and IL-1β) and MPO in colon were significantly decreased. The expression of JAK2 and STAT3 protein was reduced after administration with HJD. After JAK2/STAT3 pathway being inhibited with HJD, the cell apoptosis, collagen deposition and immunoreactivity of macrophage in colon were significantly reduced, but the expression of Ki67 was markedly enhanced in both UC group and HJD group compare with control group. CONCLUSIONS: HJD treatment can alleviate intestinal mucosal damage and has the protective effect on UC by downregulating JAK2 and STAT3 expression to reduce inflammation via JAK2/STAT3 pathway. BioMed Central 2020-05-08 /pmc/articles/PMC7206681/ /pubmed/32411291 http://dx.doi.org/10.1186/s13020-020-00327-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lu, Zhuo
Xiong, Wanna
Xiao, Simeng
Lin, Yilong
Yu, Kai
Yue, Guihua
Liu, Qiaoming
Li, Fang
Liang, Jianqin
Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title_full Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title_fullStr Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title_full_unstemmed Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title_short Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
title_sort huanglian jiedu decoction ameliorates dss-induced colitis in mice via the jak2/stat3 signalling pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206681/
https://www.ncbi.nlm.nih.gov/pubmed/32411291
http://dx.doi.org/10.1186/s13020-020-00327-9
work_keys_str_mv AT luzhuo huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT xiongwanna huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT xiaosimeng huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT linyilong huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT yukai huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT yueguihua huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT liuqiaoming huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT lifang huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway
AT liangjianqin huanglianjiedudecoctionamelioratesdssinducedcolitisinmiceviathejak2stat3signallingpathway